4.5 Article

Role of the Gut Microbiota in Children with Kidney Disease

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

Iodomethylcholine Inhibits Trimethylamine-N-Oxide Production and Averts Maternal Chronic Kidney Disease-Programmed Offspring Hypertension

You-Lin Tain et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Review Gastroenterology & Hepatology

Fecal Microbiota Transplantation Across the Lifespan: Balancing Efficacy, Safety, and Innovation

Ajay S. Gulati et al.

Summary: Fecal microbiota transplantation (FMT) is a rapidly growing therapy that aims to reconstitute the dysbiotic microbiota of a patient with the beneficial stool microbiota of a healthy individual. It has shown robust efficacy rates for recurrent Clostridioides difficile infection in both children and adults. As this field continues to grow, it is important to consider the efficacy, safety, and unique concerns across different age groups.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2023)

Article Biochemistry & Molecular Biology

Resveratrol Butyrate Ester Protects Adenine-Treated Rats against Hypertension and Kidney Disease by Regulating the Gut-Kidney Axis

Chien-Ning Hsu et al.

Summary: This study investigated the effectiveness of resveratrol butyrate ester (RBE) in protecting against hypertension and kidney damage in a rat model of chronic kidney disease (CKD). The results showed that RBE had a protective effect and could modulate gut microbiota composition and expression of short chain fatty acid receptors.

ANTIOXIDANTS (2022)

Article Urology & Nephrology

Urinary Tract Infections in Children with Vesicoureteral Reflux Are Accompanied by Alterations in Urinary Microbiota and Metabolome Profiles

Dijana Vitko et al.

Summary: There are differences in urinary commensal bacteria and metabolites between children with and without vesicoureteral reflux (VUR). These changes may be utilized to identify patients at risk of VUR-associated kidney damage.

EUROPEAN UROLOGY (2022)

Review Biochemistry & Molecular Biology

Chronic Kidney Disease and Gut Microbiota: What Is Their Connection in Early Life?

Chien-Ning Hsu et al.

Summary: The gut-kidney interaction and gut microbiota-targeted therapies have gained increasing attention in the research of chronic kidney disease (CKD). Understanding the impact of early-life gut microbiome on CKD and the development of early interventions are crucial for reducing CKD.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Urology & Nephrology

Fiber intake and health in people with chronic kidney disease

Guobin Su et al.

Summary: Emerging evidence suggests that a diet rich in fiber can prevent the progression of chronic kidney disease (CKD) and its associated complications. This review highlights the health benefits of high fiber intake in CKD patients, such as improving gut health and reducing inflammation. However, many CKD patients do not meet the recommended fiber intake, possibly due to concerns about dietary potassium. It is recommended to increase fiber intake and work with a dietitian to ensure a proper diet plan. Further research is needed to address knowledge gaps and improve patient adherence to a high-fiber diet.

CLINICAL KIDNEY JOURNAL (2022)

Article Biochemistry & Molecular Biology

Dietary Supplementation with Cysteine during Pregnancy Rescues Maternal Chronic Kidney Disease-Induced Hypertension in Male Rat Offspring: The Impact of Hydrogen Sulfide and Microbiota-Derived Tryptophan Metabolites

Chien-Ning Hsu et al.

Summary: This study found that supplementing l- or d-cysteine during pregnancy can prevent offspring hypertension caused by maternal chronic kidney disease (CKD). The protective effects are related to reducing oxidative stress, modulating the renin-angiotensin system (RAS), and reshaping the gut microbiome.

ANTIOXIDANTS (2022)

Review Pharmacology & Pharmacy

TMAO as a potential biomarker and therapeutic target for chronic kidney disease: A review

Ye Zixin et al.

Summary: The gut microbiota metabolite TMAO is closely related to chronic kidney disease, and an increased level of TMAO worsens the condition.

FRONTIERS IN PHARMACOLOGY (2022)

Review Cell Biology

Gut Microbiota-Derived Tryptophan Metabolites Maintain Gut and Systemic Homeostasis

Xiaomin Su et al.

Summary: Tryptophan, an essential amino acid, can be metabolized into different metabolites in both the gut microbiota and tissue cells. These metabolites play a critical role in maintaining gut and systematic immunity, and may potentially affect the occurrence and development of various diseases. Understanding the generation and regulation of tryptophan metabolites in the gut microbiota, as well as their role in different immune cells and immunotherapy against immune-associated diseases, is of great importance.
Article Biochemistry & Molecular Biology

Sodium butyrate modulates blood pressure and gut microbiota in maternal tryptophan-free diet-induced hypertension rat offspring

Chien-Ning Hsu et al.

Summary: Maternal nutrition, gut microbiome composition, and metabolites derived from gut microbiota are closely related to the development of hypertension in offspring. Sodium butyrate administration can prevent hypertension induced by a maternal tryptophan-free diet in adult progeny, possibly through modulating gut microbiota, its derived metabolites, and the renin-angiotensin system (RAS).

JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2022)

Article Urology & Nephrology

Inflammation in Children with CKD Linked to Gut Dysbiosis and Metabolite Imbalance

Johannes Holle et al.

Summary: Patients with chronic kidney disease (CKD) exhibit a proinflammatory immune response, potentially associated with gut dysbiosis, leading to gut barrier dysfunction and microbial metabolite imbalance, which significantly influences susceptibility to cardiovascular disease.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2022)

Article Nutrition & Dietetics

Perinatal Garlic Oil Supplementation Averts Rat Offspring Hypertension Programmed by Maternal Chronic Kidney Disease

You-Lin Tain et al.

Summary: This study demonstrates that perinatal garlic oil supplementation can protect offspring against hypertension induced by maternal CKD, by modulating H2S signaling, NO, and gut microbiota. The beneficial effects of garlic oil are associated with enhanced H2S signaling, increased NO bioavailability, and shifts in gut microbiota.

NUTRIENTS (2022)

Article Nutrition & Dietetics

Perinatal Propionate Supplementation Protects Adult Male Offspring from Maternal Chronic Kidney Disease-Induced Hypertension

You-Lin Tain et al.

Summary: Emerging evidence suggests that disturbances in early-life gut microbiota can influence adult disease. In this study, the researchers found that maternal chronic kidney disease (CKD) can lead to offspring hypertension, but perinatal supplementation of propionate can prevent this and reverse established hypertension. This protective effect is associated with increased propionate-generating bacteria, elevated plasma propionate levels, higher expression of the SCFA receptor GPR41, improved gut microbiota diversity, and shifts in composition.

NUTRIENTS (2022)

Article Pharmacology & Pharmacy

Antibiotic Resistance And Microbiota Response

Luigi Santacroce et al.

CURRENT PHARMACEUTICAL DESIGN (2022)

Review Food Science & Technology

Probiotics, prebiotics, and synbiotics for the improvement of metabolic profiles in patients with chronic kidney disease: A systematic review and meta-analysis of randomized controlled trials

Hui Juan Zheng et al.

Summary: This study systematically evaluated the effects of probiotic, prebiotic, and synbiotic supplements on biomarkers of inflammation, oxidative stress, and lipid profiles in patients with chronic kidney disease. The results showed that microbial therapies significantly lowered levels of inflammatory and oxidative stress biomarkers, as well as improved lipid profiles, highlighting the potential of these supplements in improving cardiovascular risk factors in CKD patients.

CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2021)

Review Urology & Nephrology

Specific alterations in gut microbiota in patients with chronic kidney disease: an updated systematic review

Jin Zhao et al.

Summary: The dysbiosis of gut microbiota has been found to be associated with chronic kidney disease (CKD), with specific alterations in microbial parameters identified in patients. However, differences in methodology and reporting among studies have prevented a complete understanding of the gut microbiota in CKD patients.

RENAL FAILURE (2021)

Article Nutrition & Dietetics

Clinical Significance of Probiotics for Children with Idiopathic Nephrotic Syndrome

Tadashi Yamaguchi et al.

Summary: This study suggests that oral administration of butyrate-producing bacteria during INS remission may reduce the frequency of relapse and the need for immunosuppressive agents in children, potentially through increasing the abundance of butyrate-producing bacteria and blood Treg counts.

NUTRIENTS (2021)

Review Medicine, General & Internal

The Role of Gut, Vaginal, and Urinary Microbiome in Urinary Tract Infections: From Bench to Bedside

Tomislav Mestrovic et al.

Summary: The current research focuses on the relationship between gut microbiota and the development of bacteriuria and UTI, as well as the potential impact of vaginal dysbiosis and urinary microbiome perturbations on infections. Further research and exploration are needed to understand and potentially utilize these findings for the diagnosis and treatment of UTIs.

DIAGNOSTICS (2021)

Review Biochemistry & Molecular Biology

Role of Gut Microbiota, Probiotics and Prebiotics in the Cardiovascular Diseases

Anna Oniszczuk et al.

Summary: Probiotics and prebiotics are believed to alleviate many diseases, but little is known about their role in preventing or treating cardiovascular disease. Research on the interventions of gut microbiota, probiotics, and prebiotics in cardiovascular disease is crucial.

MOLECULES (2021)

Article Pediatrics

The Association Between Changes in Plasma Short-Chain Fatty Acid Concentrations and Hypertension in Children With Chronic Kidney Disease

Pei-Chen Lu et al.

Summary: This study investigated the association between changes in plasma short-chain fatty acids (SCFAs) concentrations and cardiovascular and endothelial parameters in children with chronic kidney disease (CKD). Results showed that plasma acetate might play a role in preventing hypertension, while higher plasma propionate and butyrate concentrations seemed to imply the development of cardiovascular problems in the 1-year study period.

FRONTIERS IN PEDIATRICS (2021)

Review Immunology

Modulation of Immune Responses by Nutritional Ligands of Aryl Hydrocarbon Receptor

Alba De Juan et al.

Summary: Nutrition can modulate the immune system through metabolites, particularly acting as agonists of the Aryl hydrocarbon Receptor (AhR). Indoles and tryptophan catabolites from diet and commensal bacteria play a role in immune cell function and inflammatory disorders.

FRONTIERS IN IMMUNOLOGY (2021)

Review Transplantation

New insights into the microbiome in kidney transplantation

Joshua S. Kim et al.

Summary: Recent research has shown the important role of the microbiome in human health, particularly in kidney transplant recipients. The gut microbiota plays a crucial role in the metabolism of immunosuppressive medications and in the development of infectious and immunological complications. Future studies are needed to further understand the impact of the gut microbiota and urinary microbiome on immunosuppressive medications and outcomes in kidney transplant recipients.

CURRENT OPINION IN ORGAN TRANSPLANTATION (2021)

Review Medicine, Research & Experimental

Recent advances on the mechanisms of kidney stone formation (Review)

Zhu Wang et al.

Summary: Kidney stone disease is one of the oldest known diseases in medicine, with unclear mechanisms of formation and development. Recent technological advances have led to the development of various theories and strategies in surgical management of kidney stones. Observations suggest five main mechanisms for kidney stone formation: urinary supersaturation, Randall's plaques, sex hormones, microbiome, and immune response, providing opportunities for novel research and understanding in urology and nephrology.

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2021)

Article Immunology

Immunological Impact of a Gluten-Free Dairy-Free Diet in Children With Kidney Disease: A Feasibility Study

Maria Jose Perez-Saez et al.

Summary: The study found that a gluten-free and dairy-free diet had a significant anti-inflammatory effect in children with steroid-resistant nephrotic syndrome, promoting a favorable regulatory gut microbiota and increasing T regulatory/T helper 17 cells ratio. Further trials are necessary to explore the potential of this dietary intervention in children with SRNS.

FRONTIERS IN IMMUNOLOGY (2021)

Article Urology & Nephrology

Probiotics partially attenuate the severity of acute kidney injury through an immunomodulatory effect

Jihyun Yang et al.

Summary: The study investigated the renoprotective effects of the probiotic Bifidobacterium bifidum BGN4 on acute kidney injury (AKI) and revealed that BGN4 significantly increased gut microbiome diversity, reduced AKI-induced dysbiosis, and induced Treg cell expansion. These findings suggest that BGN4 may mitigate AKI severity through immunomodulation, making probiotics a promising strategy for reducing AKI severity and remote organ injury.

KIDNEY RESEARCH AND CLINICAL PRACTICE (2021)

Review Urology & Nephrology

Intestinal microbiota and kidney diseases

Myung-Gyu Kim et al.

Summary: Microbial communities in the gut interact with the host physiology through symbiotic relationships, affecting health. These microbes play an important role in various kidney diseases by regulating multiple mechanisms, influencing disease onset and progression.

KIDNEY RESEARCH AND CLINICAL PRACTICE (2021)

Article Urology & Nephrology

Alleviation of refractory IgA nephropathy by intensive fecal microbiota transplantation: the first case reports

Jin Zhao et al.

Summary: Preliminary evidence suggests that fecal microbiota transplantation (FMT) can be a safe and effective treatment for refractory IgA nephropathy (IgAN), potentially providing a new approach to understanding its pathogenesis. In this study, two patients with IgAN who failed to respond to traditional immunosuppressive therapy showed partial clinical remission after receiving intensive fresh FMT for 6-7 months, with improvements in proteinuria levels and kidney function. Analysis of their gut microbiota showed a restoration of biodiversity and composition following FMT, with a decrease in Proteobacteria and an increase in Prevotella.

RENAL FAILURE (2021)

Article Urology & Nephrology

Fecal microbiota transplantation for membranous nephropathy

Guanzhou Zhou et al.

Summary: Membranous nephropathy is a type of nephrotic syndrome. Current treatments are not effective for all patients, and new therapies are needed. Gut microbiota may play a role in the pathogenesis of this disease, and fecal microbiota transplantation has shown potential in treatment.

CEN CASE REPORTS (2021)

Editorial Material Medicine, General & Internal

Manipulating the Human Microbiome to Manage Disease

Catriona P. Harkins et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Pediatrics

A cross-sectional analysis of the urine microbiome of children with neuropathic bladders

Catherine S. Forster et al.

JOURNAL OF PEDIATRIC UROLOGY (2020)

Article Medicine, General & Internal

Characteristics and Dysbiosis of the Gut Microbiome in Renal Transplant Recipients

J. Casper Swarte et al.

JOURNAL OF CLINICAL MEDICINE (2020)

Article Cardiac & Cardiovascular Systems

Nonlethal Inhibition of Gut Microbial Trimethylamine N-oxide Production Improves Cardiac Function and Remodeling in a Murine Model of Heart Failure

Chelsea L. Organ et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)

Article Urology & Nephrology

Intestinal microbiota control acute kidney injury severity by immune modulation

Jihyun Yang et al.

KIDNEY INTERNATIONAL (2020)

Review Nutrition & Dietetics

Postbiotics-A Step Beyond Pre- and Probiotics

Jakub Zolkiewicz et al.

NUTRIENTS (2020)

Review Nutrition & Dietetics

Factors affecting early-life intestinal microbiota development

Yvan Vandenplas et al.

NUTRITION (2020)

Review Medicine, Research & Experimental

Microbiome-metabolome reveals the contribution of gut-kidney axis on kidney disease

Yuan-Yuan Chen et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2019)

Review Urology & Nephrology

The gut microbiota and its relationship with chronic kidney disease

Consuelo Plata et al.

INTERNATIONAL UROLOGY AND NEPHROLOGY (2019)

Review Urology & Nephrology

The Microbiome and Genitourinary Cancer: A Collaborative Review

Mark C. Markowski et al.

EUROPEAN UROLOGY (2019)

Article Multidisciplinary Sciences

Gut uropathogen abundance is a risk factor for development of bacteriuria and urinary tract infection

Matthew Magruder et al.

NATURE COMMUNICATIONS (2019)

Review Food Science & Technology

Prebiotics: Definition, Types, Sources, Mechanisms, and Clinical Applications

Dorna Davani-Davari et al.

Article Urology & Nephrology

Gut Microbiota Dysbiosis in Children with Relapsing Idiopathic Nephrotic Syndrome

Shoji Tsuji et al.

AMERICAN JOURNAL OF NEPHROLOGY (2018)

Review Urology & Nephrology

The gut microbiota and the brain-gut-kidney axis in hypertension and chronic kidney disease

Tao Yang et al.

NATURE REVIEWS NEPHROLOGY (2018)

Article Biochemistry & Molecular Biology

Gut Microbiota-Dependent Trimethylamine N-Oxide Pathway Associated with Cardiovascular Risk in Children with Early-Stage Chronic Kidney Disease

Chien-Ning Hsu et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Review Multidisciplinary Sciences

The gut microbiota at the intersection of diet and human health

Christopher L. Gentile et al.

SCIENCE (2018)

Review Critical Care Medicine

Gut-kidney crosstalk in septic acute kidney injury

Jingxiao Zhang et al.

CRITICAL CARE (2018)

Review Pediatrics

The gut-kidney axis

Pieter Evenepoel et al.

PEDIATRIC NEPHROLOGY (2017)

Review Biochemistry & Molecular Biology

Developmental Origins of Chronic Kidney Disease: Should We Focus on Early Life?

You-Lin Tain et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)

Article Urology & Nephrology

Effect of AST-120 in Chronic Kidney Disease Treatment: Still a Controversy?

Junna Yamaguchi et al.

NEPHRON (2017)

Review Biochemistry & Molecular Biology

Mechanisms and consequences of intestinal dysbiosis

G. Adrienne Weiss et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2017)

Review Medicine, General & Internal

The Human Intestinal Microbiome in Health and Disease

Susan V. Lynch et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

Editorial Material Pediatrics

World Kidney Day 2016: Averting the legacy of kidney disease-focus on childhood

Julie R. Ingelfinger et al.

PEDIATRIC NEPHROLOGY (2016)

Article Physiology

Vaginal biogenic amines: biomarkers of bacterial vaginosis or precursors to vaginal dysbiosis?

Tiffanie M. Nelson et al.

FRONTIERS IN PHYSIOLOGY (2015)

Review Pharmacology & Pharmacy

Targeting protein-bound uremic toxins in chronic kidney disease

Toshimitsu Niwa

EXPERT OPINION ON THERAPEUTIC TARGETS (2013)

Review Urology & Nephrology

The intestinal microbiota, a leaky gut, and abnormal immunity in kidney disease

Hans-Joachim Anders et al.

KIDNEY INTERNATIONAL (2013)

Review Urology & Nephrology

CKD impairs barrier function and alters microbial flora of the intestine: a major link to inflammation and uremic toxicity

Nosratola D. Vaziri

CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2012)